Dr. Moise is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4910 Mueller Blvd
Ste 103
Austin, TX 78723Phone+1 512-324-7256Fax+1 512-879-6834
Summary
- Kenneth J. Moise Jr, M.D. is Professor of Women’s Health at Dell Medical School. He also serves as the Director of the Fetal Care Center at Dell Children’s Hospital.
Dr. Moise completed his residency in Obstetrics and Gynecology at Vanderbilt University followed by a fellowship in Maternal-Fetal Medicine at Baylor College of Medicine. Dr. Moise is the former Director of Maternal-Fetal Medicine at Baylor College of Medicine and at the University of North Carolina School of Medicine. He is the former President of the International Fetal Medicine and Surgery Society and served for many years as the Treasurer/Secretary of that organization. He is a founding member of the North American Fetal Treatment Network (NAFTNet) having served on its executive board and its steering committee. He is board certified in general Obstetrics and Gynecology as well as Maternal-Fetal Medicine.
Dr. Moise’s interest in fetal therapy spans a 30-year period. He is recognized world-wide for his contributions in the fetal treatment of Rh disease including the development of middle cerebral artery Doppler for the non-invasive detection of fetal anemia and the use of free fetal DNA to determine the fetal RHD status in the U.S.. He was instrumental in the formation of the three previous fetal centers – the Center for Maternal and Infant Health at the University of North Carolina, the Texas Children’s Fetal Center in Houston and The Fetal Center at Children’s Memorial Hermann Hospital in Houston. In 2019, he was awarded the Lifetime Achievement Award by the Society for Maternal-Fetal Medicine for his work in hemolytic disease of the fetus and newborn.
Education & Training
- Baylor College of MedicineFellowship, Neonatal-Perinatal Medicine, 1985 - 1987
- Vanderbilt University Medical CenterResidency, Obstetrics and Gynecology, 1981 - 1985
- Louisiana State University School of Medicine in New OrleansClass of 1981
Certifications & Licensure
- TX State Medical License 1986 - 2026
- FL State Medical License 2019 - 2021
- NC State Medical License 1998 - 2013
- LA State Medical License 1981 - 1998
- TN State Medical License 1982 - 1992
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
- Lifetime Achievement Award Society for Maternal-Fetal Medicine, 2019
Clinical Trials
- A Noninvasive Test for Fetal RHD Genotype Start of enrollment: 2009 Apr 01
- A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN) Start of enrollment: 2018 Apr 05
Publications & Presentations
PubMed
- 33 citationsHistologic changes of the fetal membranes after fetoscopic laser surgery for twin-twin transfusion syndromeRamesha Papanna, Lovepreet K. Mann, Kenneth J. Moise, Themis R. Kyriakides, Anthony Johnson
Pediatric Research. 2015-05-28 - 17 citationsVascular limb occlusion in twin-twin transfusion syndrome (TTTS): case series and literature reviewSusanne Schrey, Agnes Huber, Kurt Hecher, Rubén A. Quintero, Fawaz Alkazaleh
American Journal of Obstetrics and Gynecology. 2012-08-01 - 35 citationsTracheoesophageal displacement index and predictors of airway obstruction for fetuses with neck massesDavid A. Lazar, Christopher I. Cassady, Oluyinka O. Olutoye, Kenneth J. Moise, Anthony Johnson
Journal of Pediatric Surgery. 2012-01-01
Press Mentions
- Cell-Free DNA Testing Delivers 100% Accuracy for Early Fetal Genotyping for Alloimmunized Pregnancies: StudyAugust 26th, 2024
- BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen™ to Help Streamline Management of Pregnant Patients Who Are AlloimmunizedSeptember 30th, 2022
- Historic First! Successful Twin to Twin Transfusion at Dell Children’sDecember 21st, 2021
- Join now to see all
Grant Support
- A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HJansen Pharmaceuticals2021–Present
- Alloimmunization To Paternal Leukocytes For HdnEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
Committees
- Member, Ethics Committee of Ascension Texas 2021 - Present
Professional Memberships
- Fellow
- Society for Maternal-Fetal MedicineMember
- American Institute of Ultrasound in MedicineMember
- International Fetal Medicine and Surgery SocietyMember
- International Society of Ultrasound in Obstetrics and GynecologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: